IXIARO
Google image searchProduct monograph
Active ingredient
inact.japanese encephal virus(attenuat. strain sa14-14-2 produced in vero cells), 6 MCG/0.5 ML
DIN: 02333279
Dosage form(s): SUSPENSION
Route(s) of administration: INTRAMUSCULAR
Schedule: Schedule D
Company: VALNEVA AUSTRIA GMBH
Date: 09-OCT-2013
ATC:
- J07 — VACCINES (ATC, ATC/DDD, )
- J07B — VIRAL VACCINES (ATC, ATC/DDD)
- J07BA — Encephalitis vaccines (ATC, ATC/DDD)
- J07BA02 — ENCEPHALITIS, JAPANESE, INACTIVATED, WHOLE VIRUS (ATC/DDD)
Reference brand drug: Ixiaro
Pharmaceutical standard: MFR
